Evidence map›Paper›PMID 40794560›Full record

ArticlePLoS biology2025

Genome-wide identification of modulators of Chlamydia trachomatis parasitophorous vacuole stability highlights an important role for sphingolipid supply.

Mohammed Rizwan Babu Sait, Lana H Jachmann, Gözde Türköz, Milica Milivojevic, Celia Llorente-Sáez, Soniya Dhanjal, Fabian Schumacher, Sara Henriksson, Naga Venkata Gayathri Vegesna, Noha Seddik and 8 more

Abstract read
In one paragraph

Article in PLoS biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Split-GFP Reporter-Based Detection of Chlamydia trachomatis Inclusion Damage.Methods in molecular biology (Clifton, N.J.) · 2027
    Article
  2. RNF213-dependent lytic destruction ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Inclusion Membrane Proteins ofMicroorganisms · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Mohammed Rizwan Babu SaitDepartment of Molecular Biology, Umeå University, Umeå, Sweden.
Lana H JachmannDepartment of Molecular Biology, Umeå University, Umeå, Sweden.
Gözde TürközDepartment of Molecular Biology, Umeå University, Umeå, Sweden.
Milica MilivojevicDepartment of Molecular Biology, Umeå University, Umeå, Sweden.
Celia Llorente-SáezDepartment of Molecular Biology, Umeå University, Umeå, Sweden.
Soniya DhanjalCRISPR Functional Genomics, SciLifeLab and Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden.
Fabian SchumacherInstitute of Pharmacy, Pharmacology and Toxicology, Freie Universität Berlin, Berlin, Germany.
Sara HenrikssonUmeå Centre for Electron Microscopy (UCEM), Umeå University, Umeå, Sweden.
Naga Venkata Gayathri VegesnaBiochemical Imaging Centre Umeå (BICU), Umeå University, Umeå, Sweden.
Noha SeddikDepartment of Molecular Biology, Umeå University, Umeå, Sweden.
Anastasiia ChabanDepartment of Molecular Biology, Umeå University, Umeå, Sweden.
Partha MohantyDepartment of Molecular Biology, Umeå University, Umeå, Sweden.
Magnus ÖlanderDepartment of Molecular Biology, Umeå University, Umeå, Sweden.
Samada MuraleedharanDepartment of Molecular Biology, Umeå University, Umeå, Sweden.
Sepideh Farmand AzadehDepartment of Molecular Biology, Umeå University, Umeå, Sweden.
Burkhard KleuserInstitute of Pharmacy, Pharmacology and Toxicology, Freie Universität Berlin, Berlin, Germany.
Bernhard SchmiererCRISPR Functional Genomics, SciLifeLab and Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Sweden.
Barbara S SixtDepartment of Molecular Biology, Umeå University, Umeå, Sweden.ORCID 0000-0002-5607-8902

Funding

Deutsche Forschungsgemeinschaft (DFG)Laboratory for Molecular Infection Medicine Sweden (MIMS)Vetenskapsrådet
6 · The paper itself

Abstract

A mechanistic understanding of how intracellular pathogens evade the intrinsic defenses of their host cells could open up intriguing therapeutic opportunities. Here, we applied a genome-wide genetic screening approach to investigate the nature of the defensive host cell death response suppressed by the membrane trafficking modulator CpoS, an effector protein secreted by the obligate intracellular bacterial pathogen Chlamydia trachomatis. Initially, this work revealed a CpoS-deficient mutant to exhibit a markedly increased dependence on host cellular synthesis of ceramides, the precursors of complex sphingolipids. Using novel microscopic reporters, we then established CpoS' role in defense evasion to occur by preserving the integrity of Chlamydia's parasitophorous vacuole (the inclusion) via ensuring an adequate sphingolipid supply. More specifically, we observed CpoS deficiency to destabilize inclusions, initially characterized by a release of individual bacteria into the host cell cytosol, then followed by inclusion rupture concomitant with host cell death. Exogenous addition of sphingosine stabilized CpoS-deficient inclusions, whereas disruption of host cellular ceramide synthesis destabilized wild-type inclusions. In combination, CpoS deficiency and impaired ceramide synthesis - presumably disrupting both Chlamydia's vesicular and non-vesicular sphingolipid supply routes - destabilized inclusions even earlier, resulting in infection clearance and host cell survival rather than host cell death. Overall, this study highlights how the vacuolar pathogen C. trachomatis maintains vacuole integrity by ensuring a steady sphingolipid supply, potentially offering inspiration and directions for future therapeutic strategies targeting parasitophorous vacuoles.

Indexed as

Chlamydia trachomatisSphingolipidsVacuolesBacterial ProteinsCeramidesChlamydia InfectionsHeLa CellsHost-Pathogen InteractionsHumansInclusion BodiesBacterial ProteinsCeramidesSphingolipids

Identifiers

PMID40794560
PMCPMC12342332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.